Form 424B3 Aerovate Therapeutics,
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20250325/ALBOW62C8M22BZZZ27292ZZZOPPQZ2Y2Z272
Filed on: March 25, 2025
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KBRA Assigns Senior Unsecured Debt Rating to Ripple Prime CIV US BD HoldCo LLC
- SPX Technologies to Report Second Quarter 2026 Financial Results
- Perion Expands Its Distribution Partner Program, Partnering With Acrossmedia241 to Bring Outmax, Its AI agent, to Greece and the CEE Region
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
